about
A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage formsAdvanced drug delivery systems for local treatment of the oral cavityDesign and evaluation of mucoadhesive oral films containing sodium hyaluronate using multivariate data analysis.Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.Physical approaches to masking bitter taste: lessons from food and pharmaceuticals.Oromucosal film preparations: classification and characterization methods.Printing technologies in fabrication of drug delivery systems.Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.Oromucosal film preparations: points to consider for patient centricity and manufacturing processes.Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.Oromucosal multilayer films for tailor-made, controlled drug delivery.Comparative study on the predictability of statistical models (RSM and ANN) on the behavior of optimized buccoadhesive wafers containing Loratadine and their in vivo assessment.In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids.Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers.Formulation, optimization and evaluation of levocetirizine dihyrochloride oral thin strip.Design expert supported mathematical optimization and predictability study of buccoadhesive pharmaceutical wafers of Loratadine.Printing of small molecular medicines from the vapor phase.Development of a taste-masked orodispersible film containing dimenhydrinate.A new method for evaluating the dissolution of orodispersible films.Pharmaceutical evaluation and dynamic vapor sorption studies of fast dissolving intraoral films of Loratadine.Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.Social aspects in additive manufacturing of pharmaceutical products.10 years EU regulation of pediatric medicines - impact on cardiovascular drug formulations.Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology.Acceptability of orodispersible films for delivery of medicines to infants and preschool children.Development and characterization of a mucoadhesive sublingual formulation for pain control: extemporaneous oxycodone films in personalized therapy.Particle engineering/different film approaches for earlier absorption of meloxicam.Hydrophobic polymers for orodispersible films: a quality by design approach.Outlining critical quality attributes (CQAs) as guidance for the development of orodispersible films.Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.Impact of super-disintegrants and film thickness on disintegration time of strip films loaded with poorly water-soluble drug microparticles.Comparison of tadalafil pharmacokinetics after administration of a new orodispersible film versus a film-coated tablet.Orally disintegrating films focusing on formulation, manufacturing process, and characterization
P2860
Q27027075-EB8F5D59-44F6-4C20-9505-7CA3CEE34F8EQ28087186-48DB2314-285B-4E85-A73F-796A17F1801FQ31107509-54E7D6A6-11AA-4F69-8E29-0DB1A0E42B22Q34712836-5979BA94-7B9B-4659-BEE1-C36B2AFF4BB4Q36981230-787B92F9-C234-48EB-9935-2D83216E013EQ38114516-56B61D91-0865-4CFB-A487-872BCCAFE355Q38164422-84DF9818-2948-44CB-AC34-C37E8827491AQ38367674-11F484D1-0CE7-46BF-ACC3-D2BE63B1713FQ38545613-63FDBA0F-913E-4EC1-96EE-6BC8375888F9Q38630904-0F44E208-F5F4-45E1-B183-F79709CE89E0Q38896329-F1C2606D-E421-4A11-9833-A87E4F8B17CFQ39044358-D78DC6B9-6B2B-4FE9-836E-4C77D66EE7AEQ39165871-568F5EEB-1071-4970-A385-7E1294FBC33FQ39934188-3079B9E9-DED1-42FA-9793-C6E1F6BBC09FQ41713132-EF569AF5-9F05-4640-97C9-86C55D2B43ACQ41862014-CFF6E6E4-6BF8-4822-A7E6-B81A209D963EQ42031679-418CE867-DA2C-475B-9C6E-01DE5162435CQ42150698-E94BF0CE-18C2-4902-B710-16BCEBD842A9Q42365551-61E21B92-4423-44E2-8044-4C94FFE479ABQ42876082-0591B580-35E0-438B-B838-B9032445CBF5Q45409859-A420EFB4-433C-406A-9BA0-F4F789D33828Q46372869-CC7223DA-C050-46B5-B08D-1061A7F959EDQ46513438-C55D787A-A2E0-4736-8E1B-8373F803E5F4Q47253580-87831537-884C-4B22-9E7E-222341B71D3FQ47760793-63062D28-D253-42E0-89F2-2D59DCAFFA31Q48012303-5BC581DF-7D34-454B-8C9E-41E738E1C05EQ48150303-0CDE346F-C2B5-4BC4-B20F-BD5CBE6D41B7Q51050209-63AD3FBD-7D22-4C9C-BBCF-915D0CBDF95AQ51137697-CA956CCE-455D-4B6E-A8CB-7066BE2E0C54Q51227521-EA6B5903-88C0-4724-8BE3-5FD8DCFFE4FAQ51278037-761B22A9-1D36-4B2B-8576-C79581043E24Q51645527-ACCA3A55-9F1F-4432-B582-6F9B22DC01DFQ52582750-1E8772BE-C80F-44CD-B38D-FF2AF848C8DFQ53069537-C29D445B-5BDC-4576-8B14-D9E151118A08Q57353643-5546175C-122F-4ADB-A510-166A6C34F728
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in orodispersible films for drug delivery.
@en
Advances in orodispersible films for drug delivery.
@nl
type
label
Advances in orodispersible films for drug delivery.
@en
Advances in orodispersible films for drug delivery.
@nl
prefLabel
Advances in orodispersible films for drug delivery.
@en
Advances in orodispersible films for drug delivery.
@nl
P2093
P2860
P1476
Advances in orodispersible films for drug delivery.
@en
P2093
Armin Breitenbach
Eva Maria Hoffmann
Jörg Breitkreutz
P2860
P304
P356
10.1517/17425247.2011.553217
P407
P577
2011-02-02T00:00:00Z